Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer
使用编码人类 vIL-2 细胞因子的溶瘤腺病毒增强过继同种异体 NK 细胞疗法的细胞毒性，以治疗人类卵巢癌
期刊:Cancer Gene Therapy
影响因子:4.8
doi:10.1038/s41417-023-00674-3
D C A Quixabeira, S Pakola, E Jirovec, R Havunen, S Basnet, J M Santos, T V Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, E Kerkelä, A Pasanen, M Anttila, J Tapper, A Kanerva, A Hemminki0
